Meg Alexander is the founder of Ovid Therapeutics. Ovid Therapeutics has raised $175M in total funding. Latest round: Growth. Based in New York, NY.
Meg Alexander is the President & Chief Executive Officer of Ovid Therapeutics, a biopharmaceutical company focused on developing small molecule medicines for brain disorders. She was appointed CEO effective January 1, 2026, after serving as President and Chief Operating Officer since 2021. Prior to Ovid, she spent over two decades guiding biopharmaceutical and Fortune 500 companies through critical growth phases, including Pfizer, Novartis, and Amgen.
Full founder directory · Investor directory · Company funding database · Fundraising library